Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Galimberti

Showing results (481-490 of 526) with videos related to

Pageof 53
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsHulya Ulugut, Kyan Younes, Maxime Bertoux, et al.
Translational Psychiatry|February 2, 2019
Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer's diseaseMaria Carolina Dalmasso, Luis Ignacio Brusco, Natividad Olivar, et al.
JAMA Neurology|June 2, 2025
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated SyndromeNicolás Fissolo, Sabine Schaedelin, Luisa M Villar, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 25, 2019
Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementiaLieke H H Meeter, Rebecca M E Steketee, Dina Salkovic, et al.
Journal of Alzheimer'S Disease : JAD|January 7, 2017
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular VolumesLinda J C van Waalwijk van Doorn, Juan D Gispert, H Bea Kuiperij, et al.
The Lancet. Neurology|February 10, 2015
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysisJonathan D Rohrer, Jennifer M Nicholas, David M Cash, et al.
Frontiers in Neurology|January 7, 2021
New Algorithms Improving PML Risk Stratification in MS Patients Treated With NatalizumabInmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis studyJean-Charles Lambert, Kristel Sleegers, Antonio González-Pérez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2025
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overviewConstance Delaby, Aurélie Ladang, Jose Martinez-Yriarte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersConstance Delaby, Aurélie Ladang, Jose Yriarte, et al.
Pageof 53

Showing results (481-490 of 526) with videos related to

Sort By:
Pageof 53
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsHulya Ulugut, Kyan Younes, Maxime Bertoux, et al.
Translational Psychiatry|February 2, 2019
Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer's diseaseMaria Carolina Dalmasso, Luis Ignacio Brusco, Natividad Olivar, et al.
JAMA Neurology|June 2, 2025
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated SyndromeNicolás Fissolo, Sabine Schaedelin, Luisa M Villar, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 25, 2019
Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementiaLieke H H Meeter, Rebecca M E Steketee, Dina Salkovic, et al.
Journal of Alzheimer'S Disease : JAD|January 7, 2017
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular VolumesLinda J C van Waalwijk van Doorn, Juan D Gispert, H Bea Kuiperij, et al.
The Lancet. Neurology|February 10, 2015
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysisJonathan D Rohrer, Jennifer M Nicholas, David M Cash, et al.
Frontiers in Neurology|January 7, 2021
New Algorithms Improving PML Risk Stratification in MS Patients Treated With NatalizumabInmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis studyJean-Charles Lambert, Kristel Sleegers, Antonio González-Pérez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2025
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overviewConstance Delaby, Aurélie Ladang, Jose Martinez-Yriarte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersConstance Delaby, Aurélie Ladang, Jose Yriarte, et al.
Pageof 53